Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
MENU
Back to Top

Submission Guidelines

Submit an article to the IPA Bulletin!

We encourage anyone in the field to submit articles to the IPA Bulletin. Please review the submission guidelines below before submitting your article to IPABulletin@ipa-online.org.

Content Deadlines

  • Volume 35, Number 1 (March 2018): 1 February 2018
  • Volume 35, Number 2 (June 2018): 1 May 2018
  • Volume 35, Number 3 (September 2018): 1 August 2018
  • Volume 35, Number 4 (December 2018): 1 November 2018

Submission Guidelines

  • All articles should be written in English and include a title.
  • Citations should be included as footnotes in the following format:
    Arai, T. et al. Biochem Biophys Res Commun.
    351: 602-11, 2006.
  • Any photos or other graphics should be sent in high-resolution as a jpg or png.
  • Please include the name, primary discipline, and contact information for each author. Including a photograph and brief bio for each author is also recommended.

IPA will perform minor edits on all articles submitted. Articles which are incomplete or deemed inappropriate by IPA and the editors will not be published. Due to space limitations, submitting an article by the content deadline does not guarantee that it will be published in that issue. Articles may be held until the next issue or reserved for a special issue.

Please send all articles and any questions you may have to IPABulletin@ipa-online.org.
Thank you for contributing to the IPA Bulletin!

Acknowledgements

Acadia Pharmaceuticals Otsuka Pharmaceuticals Cambridge University Press Avanir Pharmaceuticals
CORPORATE COUNCILS

IPA

555 E. Wells St.
Suite 1100
Milwaukee, WI 53202
United States

Tel: +1.414.918.9889
Fax: +1.414.276.3349
E-mail: info@ipa-online.org

IPA Briefs

Sign up for IPA Briefs and receive the latest announcements from IPA.

© International Psychogeriatric Association. All rights reserved.